Russia announced to be the first country who has developed vaccine against Covid-19

2020 russia announced vaccine against covid-19

The name of first corona virus vaccine is “Sputnik V” 

Finally good news came on Aug 11 th 2020, when Russia announced to be the first country who has developed vaccine against Covid-19 the Corona virus. The name of first corona virus vaccine is “Sputnik V” which is ready to use and works quite effectively against the virus.

Making his big announcement, Putin said it forms a stable immunity against corona virus informing one of his daughters has already been vaccinated using the same drug. Putin has two daughters, one of them took part in the experiment and was vaccinated against the corona virus. As world has been eager to hear the news of corona virus vaccine development now has queries including who will receive the vaccine first, market availability, cost, quantity and other information.

Russian Health Minister Mikhail Murashko said on Tuesday the vaccine had “proven to be highly
effective and safe”, hailing it as a big step towards “humankind’s victory” over Covid-19.

When production of Covid-19 vaccine is expected?

As per experts the Russian vaccine uses adapted strains of the adenovirus, a virus that usually causes the common cold, to trigger an immune response. However Russia has developed limited doses of the first corona virus vaccine, as has got regulatory approval, the industrial production of the vaccine may start in Oct 2020. 

Meanwhile the Moscow-based Association of Clinical Trials Organizations (Acto), which represents the world’s top drug companies in Russia, urged the health ministry to postpone approval until after phase-three trials – BBC

WHO concern on Russian Covid-19 vaccine?

In the current progress on Covid-19 vaccine the World Health Organization (WHO) urged Russia last week to follow international guidelines for producing. The WHO said it had been in talks with Russian authorities about undertaking a review of the vaccine. As of Aug 2020 the Russian vaccine is not among the WHO’s list of six vaccines that have reached phase three clinical trials, which involve more widespread testing in humans.

Leave a Reply

Your email address will not be published. Required fields are marked *